Pfizer might have felt singled out a while back when Sen. Sherrod Brown [1] demanded details of its outsourcing program. How much, the senator wanted to know, of the company's outsourcing went to countries with less stringent oversight? Well, now Pfizer isn't alone: The senator has sent Merck a letter asking for similar information. And as in Pfizer's case, the request follows a statement from a company exec about the growth of their companies' outsourcing activities. Report [2]
Links:
[1] http://www.fiercepharma.com/story/senator-calls-outsourcing-probe-fda/2008-06-17
[2] http://www.fiercepharma.com/story/senator-demands-merck-outsourcing-info/2008-07-25